AI Giant Microsoft Leads 5 Stocks Near Buy Points

AI Giant Microsoft Leads 5 Stocks Near Buy Points

Microsoft (MSFT), Novo Nordisk (NGO) And Intuitive surgical (ISRG) are among the top stocks to watch this week as they settle into bases after regaining key levels. Apollo Global Management (APO) And Reservation of funds (BKNG) was also retained.


Microsoft shares can be found on the Long-term leaders in IBD list. Novo Nordisk is owned by MII classification as good as IBD 50 List of Top Growth Stocks. Intuitive Surgical landed a spot on SwingTrader IBD On May 15, as stocks surged.

THE lines of relative force of the top five stocks to buy and watch have flattened a bit after the rallies, but remain close to the highs. A rising RS line, the blue line in the charts shown, means a stock is outperforming relative to the S&P 500 Index.

THE sotck exchange sent a green signal to investors on Thursday, with major indexes hitting record highs.

Microsoft Stocks

Shares of the tech giant climbed for a fourth straight week, rebounding from the 10-week moving average. Microsoft stock shows 430.82 point of purchase on an eight-week flat base, still 2% below entry. Investors could use a move back above Thursday’s high at 425.42 as an early entry into the trendline.

Keep in mind that: Nvidia (NVDA) publishes its results on Wednesday, May 22, after the close. This report could have a significant impact on Microsoft shares. Both Nvidia and Microsoft are considered leaders in artificial intelligence. Both are also among the Seven magnificent actions which has fueled the market rally over the past year.

Microsoft itself released its third-quarter financial results on April 25. On an annual basis, Microsoft profits increased by 20% while sales increased by 17%. The strength of the cloud computing sector has generated solid gains.

Analysts now expect profit growth of 20% for the full year and another 13% next year. Sales are expected to increase by 15% and 14% over the same periods.

Microsoft wins a IBD Composite Rating of 84 and an EPS rating of 96, both on the best 99 possible. An RS Rating of 78 means it has outperformed 78% of all stocks in IBD’s database over the past year.

Dow closes above 40,000; All eyes on Nvidia’s profits

Novo Nordisk shares

Shares of manufacturer Wegovy rebounded for a second consecutive week, returning to the 10-week line. Novo Nordisk stock is targeting a 138.28 buy point from a shallow cup base, still 5% below the entry. This is a 24% increase from a previous flat base breakout in January, the MarketSurge Pattern Recognition watch.

Stocks fell late last week. It’s possible Novo could start working on a handle, which would offer a lower buy point.

Novo Nordisk stock has an IBD Composite Rating of 96, an EPS Rating of 97 and an RS Rating of 89.

May 2nd, the company recorded a 25% increase in EPS and a 19% revenue increase for the first quarter. Long known for its diabetes treatments, Denmark-based Novo Nordisk has continued to innovate. Its Ozempic and Wegovy treatments for diabetes and weight loss have spurred growth.

Analysts expect earnings growth of 23% in 2024 and 23% in 2025.

Intuitive surgical stock

Shares of the maker of robotic surgery systems rose for the fourth straight week, retaking the 10-week line. Intuitive Surgical stock is working off a flat base buy point of 403.76, still 2% below entry. Investors could still use Wednesday’s move above the 50-day line as an early entry.

Intuitive stock holds an IBD Composite Rating of 90, an EPS Rating of 92 and an RS Rating of 83.

On April 19, the company revealed that profits soared 22% in the first quarter while sales increased by 11.5%.

Analysts forecast earnings growth of 10% in 2024 and 17% in 2025.

Apollo Global Management Stocks

Shares of the investment company rose for the second week in a row, above the 10-week line. The MarketSurge shows Apollo Global Management stock on a six-week flat base with a buy point of 117.15.

Investors could use Wednesday’s high at 115.48 as an early entry.

Apollo Global stock holds an IBD Composite Rating of 93, an EPS Rating of 95 and an RS Rating of 88.

On May 2, the company reported a 21% increase in first-quarter EPS, while sales increased 13%. This report arrived a few days later Apollo announced that it would acquire U.S. silica holdings (SLCA) in a $1.85 billion deal, stripping the supplier of commercial silica used in the oil and gas industry.

Analysts forecast earnings growth of 12% in 2024 and 20% in 2025.

Reservation of stock securities

Shares of the travel company retreated after a three-day winning streak, still holding above the 10-week line. Booking Holdings shares formed a double-bottom base, forging a handle as early as Friday. This gives Booking a buy point of 3,811.57.

The handle formed after several days of following gains.

The reserve stock holds an IBD Composite Rating of 94, an EPS Rating of 98, and an RS Rating of 75.

On May 2, the parent company behind, Priceline and Kayak reported a 76% increase in first-quarter EPS on a 17% gain in sales. Booking takes shares from its rival Expedia (EXPÉ), analysts said after the report was released. The company said global leisure travel remains resilient heading into the key summer season.

Analysts forecast earnings growth of 16% in 2024 and 17% in 2025.


Why this MII tool simplifies To inputch For the best actions

Best Chinese Stocks to Buy and Watch

Best Growth Stocks to Buy and Watch

IBD Digital: Unlock IBD’s premium stock lists, tools and analysis today

Are you looking for market information? Check out our daily live IBD segment

Source Reference

Latest stories